Our results demonstrated that IFNβ was able to extend tPA therapeutic window to 4.5h post-injury and that was accompanied with ameliorated brain injury and lessened BBB disruption in ischemic stroke. This evidence concerns the gene IFNB1 and ischemic stroke.